Medicago signs MOU with Ajanta Pharma for commercial development of influenza vaccines in India and other territories
25-Aug-2009 -
Medicago Inc. announced that it has signed a Memorandum of Understanding ("MOU") with Ajanta Pharma Limited to discuss and negotiate an agreement to commercialize Medicago's pandemic and seasonal influenza VLP-based vaccines in India and other territories. Under the terms of the MOU, the parties ...
business development
seasonal influenza
vaccines